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Abstract: Background: Impaired physical performance is highly prevalent in older cancer patients
and is associated with cancer-related outcomes such as mortality and chemotherapy-
related toxicity. Physical performance might already decline prior to the cancer
diagnosis due to undiagnosed disease. This study aimed to assess whether the
physical performance of community-dwelling individuals prior to cancer diagnosis is
worse compared to matched controls who are not diagnosed with cancer.
Methods: The study sample was selected from the Longitudinal Aging Study
Amsterdam, a longitudinal study on a nationally representative sample of the Dutch
older population. Physical performance of initially cancer-free individuals aged 55-84
years who were diagnosed with cancer during 10 or 20 years of follow-up was
compared to the physical performance of controls who were not diagnosed with
cancer. For controls, the physical performance measurements of the cycle with a
median age closest to the cancer group were used. The time interval between physical
performance measurements and the report of cancer was two to four years. Groups
were compared using logistic and linear regression analysis.
Results: The study sample included 1735 individuals with a median age of 68.7
[interquartile range 63.3-76.4] years. During follow-up, 414 (23.9%) individuals were
diagnosed with cancer. Handgrip strength, gait speed, chair stand ability, chair stand
test time and ability to put on and take off a cardigan did not differ between groups.
Individuals prior to cancer diagnosis were more likely to complete the tandem balance
test.
Conclusions: Physical performance of individuals two to four years prior to report of
cancer diagnosis is not lower compared to controls. This suggests that physical
performance may not be influenced by cancer before diagnosis.
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Background: Impaired physical performance is highly prevalent in older cancer 2 
patients and is associated with cancer-related outcomes such as mortality and 3 
chemotherapy-related toxicity. Physical performance might already decline prior to 4 
the cancer diagnosis due to undiagnosed disease. This study aimed to assess 5 
whether the physical performance of community-dwelling individuals prior to cancer 6 
diagnosis is worse compared to matched controls who are not diagnosed with 7 
cancer. 8 
Methods: The study sample was selected from the Longitudinal Aging Study 9 
Amsterdam, a longitudinal study on a nationally representative sample of the Dutch 10 
older population. Physical performance of initially cancer-free individuals aged 55-84 11 
years who were diagnosed with cancer during 10 or 20 years of follow-up was 12 
compared to the physical performance of controls who were not diagnosed with 13 
cancer. For controls, the physical performance measurements of the cycle with a 14 
median age closest to the cancer group were used. The time interval between 15 
physical performance measurements and the report of cancer was two to four years. 16 
Groups were compared using logistic and linear regression analysis. 17 
Results: The study sample included 1735 individuals with a median age of 68.7 18 
[interquartile range 63.3-76.4] years. During follow-up, 414 (23.9%) individuals were 19 
diagnosed with cancer. Handgrip strength, gait speed, chair stand ability, chair stand 20 
test time and ability to put on and take off a cardigan did not differ between groups. 21 
Individuals prior to cancer diagnosis were more likely to complete the tandem 22 
balance test.  23 
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Conclusions: Physical performance of individuals two to four years prior to report of 24 
cancer diagnosis is not lower compared to controls. This suggests that physical 25 
performance may not be influenced by cancer before diagnosis.  26 
Keywords: Aged, older, geriatrics, oncology, cancer, neoplasms, physical 27 





































































Decreased physical performance is highly prevalent in older patients who have been 30 
diagnosed with cancer.[1-6] Almost half of older cancer patients experience problems 31 
with walking[7, 8] while this is approximately 20-30% in the general older 32 
population.[9, 10] Moreover, approximately 25% of older cancer patients have 33 
mobility impairment measured by a prolonged timed up and go test[11-13] with a 34 
median time of 17-24 seconds[12, 13] while the mean time to perform the timed up 35 
and go test in the general older population is 8.7-10 seconds.[14-16] The importance 36 
of physical performance in older cancer patients has been highlighted by its 37 
predictive power for clinically relevant outcomes such as mortality and 38 
chemotherapy-related toxicity.[13, 17-21] 39 
Physical performance of individuals who have been diagnosed with cancer 40 
shows a greater decline than matched controls not suffering from cancer,[5, 22] 41 
which may be caused by cachexia due to the disease[23] or chemotherapy 42 
treatment.[12, 24, 25] The majority of individuals with cancer who did not receive 43 
chemotherapy treatment in the previous four weeks, show a decrease in body 44 
weight.[26, 27] This weight loss might be a consequence of muscle wasting and 45 
therewith influencing physical performance. Self-reported physical ability to perform 46 
several daily routine activities three months prior to cancer diagnosis has been 47 
reported to be better than after initial treatment eight weeks after diagnosis.[28] 48 
Another study showed that self-reported physical performance within one year after 49 
cancer diagnosis was lower compared to a group without cancer.[22] In the three 50 
years before cancer diagnosis the self-reported physical performance was only lower 51 
in the group with lung cancer compared to individuals without cancer.[22]  These 52 




































































was objectively lower or when decline took place. Self-reported physical performance 54 
can be influenced by a variety of (subjective) factors unrelated to actual physical 55 
performance such as state of mind, and are probably less sensitive to minor changes 56 
than objective physical performance measures. Evidence about the occurrence of 57 
objective decline in physical performance prior to cancer diagnosis is therefore 58 
important; it may be used as an indicator for undiagnosed cancers and it may be 59 
predictive of recovery relating to cancer treatment.  60 
The aim of this study was to examine whether objectively measured physical 61 
performance of individuals prior to the diagnosis of cancer was worse compared to 62 
individuals who did not develop cancer in a large community sample of older adults. 63 
We hypothesized that physical performance of individuals prior to cancer diagnosis 64 
would be lower than the physical performance of individuals without cancer due to a 65 





































































Study design and procedures 68 
The study sample was selected from the Longitudinal Aging Study Amsterdam 69 
(LASA), a longitudinal study on a nationally representative sample of the Dutch older 70 
population among 3107 community dwelling individuals aged 55-84 years (first 71 
cohort, 1992-1993) and 1002 individuals aged 55-64 years (second cohort, 2002-72 
2003).[29] Individuals were followed about every three years since these baseline 73 
measurements. Thus after the baseline measurement of cohort one in 1992-1993, a 74 
second cohort was added in 2003-2003 and the latest follow-up included in this study 75 
took place in 2011-2011. Detailed information on data procedures and collection has 76 
been published elsewhere.[29, 30] The study has been approved by the Medical 77 
Ethics Committee of the VU University Medical Center in Amsterdam. 78 
Study sample 79 
Individuals were divided into a cancer group and control group based on self-report 80 
of having cancer during any of the follow-up measurements. To determine the 81 
physical performance of cancer patients prior to their diagnosis, the measurement 82 
cycle before they reported to have cancer for the first time was used for analysis. 83 
After the baseline and follow-up interviews of 2001-2002, 2005-2006 and 2008-2009, 84 
information on presence of cancer was also obtained from general practitioners by 85 
use of a questionnaire. As self-reports of cancer were fairly accurate compared to 86 
reports of general practitioners (1992-1993 kappa=0.64 (0.58-0.70) and 2008-2009 87 
kappa=0.64 (0.57-0.70), the cancer group in this study was based on self-report of 88 
cancer.[31, 32] Individuals were included in the cancer group if they reported cancer 89 




































































they reported cancer at baseline (n=372); 2) they did not participate in the most 91 
recent interview before reporting cancer (n=9); 3) no physical performance tests were 92 
conducted during the interview before reporting cancer (n=2). The number of 93 
individuals included in the cancer group was N=414. 94 
The control group consisted of individuals who reported no cancer at baseline nor 95 
during the complete ten (cohort 2) to twenty (cohort 1) years of follow-up. The 96 
measurement cycle of the year 2005-2006 was chosen as the physical performance 97 
measurement for the control group, since the median age of individuals in this cycle 98 
was nearest to the median age of the individuals diagnosed with cancer. Individuals 99 
were excluded from the control group if: 1) they died before the interview in 2005-100 
2006, did not participate in the interview or data of the interview or physical 101 
performance measurements were missing in 2005-2006 (n=1865); 2) they did not 102 
report presence of cancer at any of the interviews but the general practitioner did 103 
(n=116), to maximize the probability that the controls were cancer free. The number 104 
of individuals included in the control group was N=1321. Figure 1 illustrates the 105 
selection of the study sample from the cohort. 106 
Characteristics of study sample 107 
Data on age, gender, lifestyle factors, anthropometry and health characteristics were 108 
included as covariates. Lifestyle variables included current smoking status and 109 
alcohol use. Current smoking status (never, former and current smoker) was 110 
dichotomized into yes (current smoker) or no (never or former smoker). Alcohol 111 
consumption was measured with an adaptation of the alcohol consumption index by 112 
Garretsen.[33] This index was categorized into (very) excessive alcohol use, 113 




































































included height, weight and body mass index (BMI). Health characteristics included 115 
cognitive functioning, number of chronic diseases and number of medicines used per 116 
day. Cognitive functioning was measured by the Mini Mental State Examination 117 
(MMSE).[34] Number of chronic diseases was obtained by asking explicitly about the 118 
presence of six prevalent somatic chronic diseases (chronic non-specific lung 119 
disease including asthma and chronic obstructive pulmonary disease, cardiac 120 
disease, peripheral arterial disease, diabetes mellitus, cerebrovascular accident, and 121 
osteoarthritis or rheumatoid arthritis.[35, 36] The medicines taken by the respondent 122 
were recorded from the containers by the interviewer. 123 
Physical performance 124 
Physical performance was assessed at respondents’ homes and included handgrip 125 
strength (HGS), six-meter walking (6MWT), chair stand (CST), tandem balance and 126 
putting on and taking off a cardigan. HGS was measured using a grip strength 127 
dynamometer that was adjusted for hand size and recorded the grip strength to the 128 
nearest kilogram (Takei TKK 5001, Takei Scientific Instruments Co. Ltd., Tokyo, 129 
Japan). HGS was measured twice for both the left and right hand. Maximum HGS 130 
was determined by the highest grip strength. Gait speed was assessed by time in 131 
seconds doing the 6MWT which consists of walking three meters, turn around and 132 
walk three meters back as quickly as they can. Gait speed was measured in meters 133 
per second by dividing six meters by the time to do the test. The CST was used to 134 
assess the ability of individuals to rise from a chair with their arms crossed over their 135 
chest, stand up to a straight position and sit down again. This test was performed five 136 
times. The ability and the time in seconds needed to perform the CST were used for 137 




































































directly in front of the other foot, making sure that the toes of the back foot are 139 
touching the heel of the front foot. The ability to remain in tandem stand for ten 140 
seconds was used for analysis. The cardigan test measured the time in seconds 141 
required to put on and take off a cardigan. 142 
Data analysis 143 
Dichotomous variables were presented as number and percentage. Continuous 144 
variables were presented by mean, standard deviation if data was normally 145 
distributed or median, interquartile range (IQR) if data was skewed. Differences in 146 
population characteristics were analyzed with a chi-square test for dichotomous 147 
variables, an independent samples t-test for continuous variables and Mann-Whitney 148 
U test if continuous data was skewed. Physical performance of individuals prior to the 149 
diagnosis cancer and controls was compared using multiple logistic (CST and 150 
tandem balance test ability) and linear (HGS, gait speed, CST time, cardigan time) 151 
regression models including stepwise adjustment for possible confounders including 152 
gender and age and height, weight, current smoking and number of chronic 153 
diseases. Diagnosis of cancer was defined as the independent variable and was 154 
coded (0) no cancer and (1) cancer. Physical performance measurements were 155 
defined as the dependent variables. P-values of less than 0.05 were considered 156 
statistically significant. Statistical analyses were performed using Statistical Package 157 





































































Study sample 160 
The median age of the total study sample was 68.7 [IQR 63.3-76.4] years. Table 1 161 
shows the characteristics of the group prior to diagnosis of cancer and the control 162 
group. None of the characteristics (age, gender, smoking, alcohol, anthropometric 163 
measurements or health characteristics) differed significantly between the cancer and 164 
the control group. 165 
Physical performance prior to diagnosis of cancer 166 
Table 2 shows the mean physical performance and Table 3 shows the proportions of 167 
individuals prior to cancer diagnosis and controls on the physical performance 168 
measurements. Both tables also show the association between cancer diagnosis and 169 
physical performance in models adjusted for gender and age (model 1) and for 170 
additional potential confounders (model 2). HGS, gait speed, ability and time to 171 
perform the CST and the cardigan test did not differ between individuals prior to 172 
cancer diagnosis and controls. Individuals prior to cancer diagnosis were more likely 173 
to be able to remain in tandem position for ten seconds than controls, also after 174 
adjustment for possible confounders. Results did not differ when individuals of whom 175 
the general practitioner reported cancer while the individuals themselves did not, 176 




































































Discussion  178 
This longitudinal study of nationally representative older individuals showed that 179 
physical performance was not lower in individuals two to four years prior to the report 180 
of cancer compared to individuals who were not diagnosed with cancer and therefore 181 
did not support our hypothesis.  182 
Unintentional weight loss is often one of the alarming symptoms of 183 
undiagnosed cancer. Individuals who lose weight, can lose both fat mass and muscle 184 
mass.[37-41] In this context, body weight can be a misleading marker as individuals 185 
might not lose weight if fat mass or body water increases. Low muscle mass on the 186 
other hand is an important determinant of low muscle strength, low physical 187 
performance and functional disability.[42-46] We expected that physical performance 188 
could already be lower in cancer patients prior to their diagnosis than in individuals 189 
without cancer. Lower physical performance could therewith be another alarming 190 
symptom for clinicians and individuals to pay attention to and might even be a first 191 
indicator. Possibly, there could even be a role for improving physical performance 192 
prior to cancer treatment. However, our results did not confirm our expectation. Even 193 
though a decline prior to cancer treatment has not been found, we still believe 194 
improving physical performance should be an important part of cancer treatment. 195 
Lower physical performance is associated with a higher risk on adverse outcome[13, 196 
17-21], therefore patients could benefit from physical performance interventions prior, 197 
during and after cancer treatment, especially since a decline in physical performance 198 
is expected during the course of treatment.[5, 22] 199 
The physical performance of individuals was analyzed by use of several 200 
physical tests including HGS, gait speed, CST, time to put on and take off a cardigan 201 




































































commonly used tests in clinical practice as well as research and are used to 203 
determine muscle strength and physical performance.[47-52] The cardigan test is 204 
less known in clinical practice and relates to activities of daily living and relies on 205 
coordination and on the functioning of the upper extremities. Even though the tandem 206 
test is a balance test, it is influenced by core stability which is also dependent of 207 
physical function. This test might be less reproducible than other physical 208 
performance measurements.[53] The finding that individuals prior to cancer diagnosis 209 
were more likely to be able to successfully perform the tandem balance test was 210 
unexpected and cannot be explained by current literature describing insights in 211 
cancer pathophysiology. 212 
The main strength of this study is the use of objective, well-validated 213 
measures of physical performance including handgrip strength, gait speed and 214 
balance tests. Another major strength is that this study included a large 215 
heterogeneous community-based sample of older individuals.  216 
Study Limitations 217 
A limitation of this study is that actual cancer diagnosis could have occurred anytime 218 
between the two measurements varying from one day to four years. Unfortunately, it 219 
was not possible to adjust for the effect of the time interval between measurement of 220 
physical performance and cancer diagnosis because the actual date of cancer 221 
diagnosis is unknown, there is only information on the date that individuals reported 222 
to have cancer during any of the measurement cycles. Furthermore, presence of 223 
cancer was based on self-report of individuals. Although there was substantial 224 
accuracy in the self-report of individuals,[31, 32] self-report could still have led to 225 




































































is most likely[32, 54] and underreport is more common in individuals without mobility 227 
limitations[32]. Thus, if there was substantial underreport of cancer, it will not have 228 
changed the results and conclusions of this study as it will have led to more 229 
individuals with higher physical performance in the cancer group. Moreover, controls 230 
were matched based on the median age of the cancer group and not per individual. 231 
However, the groups proved to be comparable in major sociodemographic 232 
characteristics. Lastly, the cancer group included all types and severity of cancer and 233 
it may be argued that some types of tumor would have a larger influence on physical 234 
performance and that more severe stages of cancer will also have a bigger impact on 235 
physical performance. This argument is supported by the study of Petrick et al. which 236 
showed that self-reported physical performance was only significantly lower in the 237 





































































Objectively measured physical performance of older individuals prior to cancer 240 
diagnosis was not lower than of controls who were not diagnosed with cancer. This 241 
indicates that physical performance in the time period of two to four years prior to 242 
report of cancer diagnosis is not negatively influenced by cancer, when all cancer 243 
types and stages of cancer are taken into account. Future research should focus on 244 
measurements of physical performance more closely prior to diagnosis of cancer and 245 
analyze different types and stages of cancer to be able to conclude on the trajectory 246 




































































Figure captions 248 




































































List of abbreviations 250 
6MWT: Six Meter Walking Test 251 
BMI: Body Mass Index 252 
CST: Chair Stand Test 253 
HGS: Handgrip Strength  254 
IQR: Interquartile Range  255 
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Table 1: Characteristics of the study group prior to the diagnosis of cancer and 443 
control group.  444 







     
Age, years, median [IQR] 414 69.2 [63.7-75.8] 1321 68.6 [63.0-76.6] 0.498 
Female   414 205 (49.5) 1321 720 (54.5) 0.076 
Current smoking  369 75 (20.3) 1269 220 (16.7) 0.191 
Alcohol use 369  1266  0.979 
       No alcohol  57 (15.4)  195 (15.4)  
       Moderate/light  290 (78.6)  999 (78.9)  
       (Very) excessive   22 (6.0)  72 (5.7)  
Anthropometry       
Body weight, kg, mean ± SD 362 77.9 ± 13.6 1245 78.4 ± 13.4 0.590 
Height, cm, mean ± SD 360 168.7 ± 9.3 1244 168.6 ± 9.3 0.913 
BMI, kg/m2, mean ± SD 359 27.4 ± 4.2 1237 27.6 ± 4.3 0.364 
Health characteristics      
Nr chronic diseases, median [IQR] 414 1 [0-2] 1321 1 [0-2] 0.726 
Nr of medicines, median [IQR] 332 2 [1-4] 1269 2 [0-4] 0.853 
MMSE, median [IQR] 414 28 [27-29] 1321 28 [27-29] 0.064 
 445 
All variables are presented in numbers (percentage) unless indicated otherwise. 446 
Alcohol was based on the Garretsen indication of present alcohol use and was 447 
categorized into three groups. IQR: interquartile range; SD: standard deviation; 448 




































































kilograms; cm: centimeters; m2: square meters; nr: number; s: seconds; m/s: meters 450 
















































































Variables are given in mean ± SD unless indicated otherwise. P-values were significant if < 0.05. Model 1: adjusted for gender and 464 
age. Model 2: model 1 plus height, weight, current smoking status and number of chronic diseases. Chair stand test in seconds was 465 
only calculated for individuals who could perform the test five times. B1: regression coefficient; SE: standard error; p: p-value; HGS: 466 
handgrip strength; kg: kilograms; SD: standard deviation; m/s: meters per second; CST: chair stand test; s: seconds.   467 
      Cancer, yes 

















































Gait speed, m/s 404 0.9 ± 0.3 1246 0.9 ± 0.3 1533 -0.007 0.015 0.640  -0.006 0.015 0.685 
CST, s 376 12.1 ± 3.8 1164 12.5 ± 3.8 1434 -0.216 0.217 0.320  -0.184 0.212 0.387 




































































Table 3: Logistic regression of the association between the diagnosis of cancer and physical performance measurements.  468 
 469 
 470 
Variables are given in N (percentage) unless indicated otherwise. P-values were significant if < 0.05. Model 1: adjusted for gender 471 
and age. Model 2: model 1 plus height, weight, current smoking status and number of chronic diseases. Chair stand test was 472 
scored as able if the individual was able to perform the test five times. Tandem balance test was scored as able if the individual 473 
could remain in tandem position for at least ten seconds. OR: Odds Ratio; 95% CI: 95% Confidence Interval; p: p-value; CST: chair 474 
stand test. 475 
      Cancer, yes 























             
CST, able 404 378 (93.6) 1233 1169 (94.8) 1514 0.830 0.479-1.440 0.507  0.819 0.464-1.444 0.490 
Tandem balance 
test, able 


































































First and second LASA cohort  
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Died before 2005-06 or 
did not participate/data 
missing of 2005-06
N=1865
Cancer at baseline 
N=372
Unknown when cancer 
was developed 
N=10








records show cancer 
N=116
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